Cargando…

Quantitative assessment of diffuse myocardial fibrosis and edema in patients with and without cardiac involvement of sarcoidosis by cardiovascular magnetic resonance T1- and T2-mapping at 1.5T

Detalles Bibliográficos
Autores principales: Dabir, Darius, Luetkens, Julian A, Kuetting, Daniel, Homsi, Rami, Marx, Christian, Kluenker, Folke, Schild, Hans H, Thomas, Daniel K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032334/
http://dx.doi.org/10.1186/1532-429X-18-S1-P255
_version_ 1782454975863980032
author Dabir, Darius
Luetkens, Julian A
Kuetting, Daniel
Homsi, Rami
Marx, Christian
Kluenker, Folke
Schild, Hans H
Thomas, Daniel K
author_facet Dabir, Darius
Luetkens, Julian A
Kuetting, Daniel
Homsi, Rami
Marx, Christian
Kluenker, Folke
Schild, Hans H
Thomas, Daniel K
author_sort Dabir, Darius
collection PubMed
description
format Online
Article
Text
id pubmed-5032334
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50323342016-09-29 Quantitative assessment of diffuse myocardial fibrosis and edema in patients with and without cardiac involvement of sarcoidosis by cardiovascular magnetic resonance T1- and T2-mapping at 1.5T Dabir, Darius Luetkens, Julian A Kuetting, Daniel Homsi, Rami Marx, Christian Kluenker, Folke Schild, Hans H Thomas, Daniel K J Cardiovasc Magn Reson Poster Presentation BioMed Central 2016-01-27 /pmc/articles/PMC5032334/ http://dx.doi.org/10.1186/1532-429X-18-S1-P255 Text en © Dabir et al. 2016 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Dabir, Darius
Luetkens, Julian A
Kuetting, Daniel
Homsi, Rami
Marx, Christian
Kluenker, Folke
Schild, Hans H
Thomas, Daniel K
Quantitative assessment of diffuse myocardial fibrosis and edema in patients with and without cardiac involvement of sarcoidosis by cardiovascular magnetic resonance T1- and T2-mapping at 1.5T
title Quantitative assessment of diffuse myocardial fibrosis and edema in patients with and without cardiac involvement of sarcoidosis by cardiovascular magnetic resonance T1- and T2-mapping at 1.5T
title_full Quantitative assessment of diffuse myocardial fibrosis and edema in patients with and without cardiac involvement of sarcoidosis by cardiovascular magnetic resonance T1- and T2-mapping at 1.5T
title_fullStr Quantitative assessment of diffuse myocardial fibrosis and edema in patients with and without cardiac involvement of sarcoidosis by cardiovascular magnetic resonance T1- and T2-mapping at 1.5T
title_full_unstemmed Quantitative assessment of diffuse myocardial fibrosis and edema in patients with and without cardiac involvement of sarcoidosis by cardiovascular magnetic resonance T1- and T2-mapping at 1.5T
title_short Quantitative assessment of diffuse myocardial fibrosis and edema in patients with and without cardiac involvement of sarcoidosis by cardiovascular magnetic resonance T1- and T2-mapping at 1.5T
title_sort quantitative assessment of diffuse myocardial fibrosis and edema in patients with and without cardiac involvement of sarcoidosis by cardiovascular magnetic resonance t1- and t2-mapping at 1.5t
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032334/
http://dx.doi.org/10.1186/1532-429X-18-S1-P255
work_keys_str_mv AT dabirdarius quantitativeassessmentofdiffusemyocardialfibrosisandedemainpatientswithandwithoutcardiacinvolvementofsarcoidosisbycardiovascularmagneticresonancet1andt2mappingat15t
AT luetkensjuliana quantitativeassessmentofdiffusemyocardialfibrosisandedemainpatientswithandwithoutcardiacinvolvementofsarcoidosisbycardiovascularmagneticresonancet1andt2mappingat15t
AT kuettingdaniel quantitativeassessmentofdiffusemyocardialfibrosisandedemainpatientswithandwithoutcardiacinvolvementofsarcoidosisbycardiovascularmagneticresonancet1andt2mappingat15t
AT homsirami quantitativeassessmentofdiffusemyocardialfibrosisandedemainpatientswithandwithoutcardiacinvolvementofsarcoidosisbycardiovascularmagneticresonancet1andt2mappingat15t
AT marxchristian quantitativeassessmentofdiffusemyocardialfibrosisandedemainpatientswithandwithoutcardiacinvolvementofsarcoidosisbycardiovascularmagneticresonancet1andt2mappingat15t
AT kluenkerfolke quantitativeassessmentofdiffusemyocardialfibrosisandedemainpatientswithandwithoutcardiacinvolvementofsarcoidosisbycardiovascularmagneticresonancet1andt2mappingat15t
AT schildhansh quantitativeassessmentofdiffusemyocardialfibrosisandedemainpatientswithandwithoutcardiacinvolvementofsarcoidosisbycardiovascularmagneticresonancet1andt2mappingat15t
AT thomasdanielk quantitativeassessmentofdiffusemyocardialfibrosisandedemainpatientswithandwithoutcardiacinvolvementofsarcoidosisbycardiovascularmagneticresonancet1andt2mappingat15t